BeOne Medicines AG
ONC | NASDAQ
$387.25
+$9.47 (+2.51%)
At close: Nov 5, 2026, 4:00 PM ET
$381.50
-$5.75 (-1.48%)
After-hours:
Nov 5, 2026, 5:55 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.71B | 1.51B | 1.5B | 1.41B | 1.32B | 1.12B | 1.13B | 1B | 929.17M | 751.65M | 634.41M | 781.31M | 595.26M | 447.8M | 380.1M | 387.63M | 341.57M | 306.63M | 213.98M | 206.44M | 149.99M | 605.87M |
Cost of Revenue | 174.53M | 167.22M | 142.42M | 196.51M | 164.61M | 165M | 160.56M | 170.46M | 138.13M | 124.94M | 105.83M | 96.31M | 95.99M | 81.79M | 73.52M | 76.54M | 71.17M | 65.24M | 48.55M | 47.41M | 36.26M | 32.69M |
Gross Profit | 1.53B | 1.35B | 1.36B | 1.22B | 1.15B | 952.28M | 967.26M | 831.14M | 791.03M | 626.72M | 528.58M | 685M | 499.27M | 366.01M | 306.57M | 311.09M | 270.4M | 241.39M | 165.43M | 159.03M | 113.73M | 573.19M |
Operating Income | 325.05M | 249.9M | 185.04M | 163.11M | 87.89M | 11.1M | -79.43M | -120.27M | -107.16M | -261.35M | -383.8M | -133.97M | -318.72M | -371.26M | -468.62M | -438.36M | -439.4M | -443.29M | -571.74M | -462.33M | -474.84M | 70.17M |
Interest Income | 27.9M | 27.66M | 58.13M | 3.03M | 3.5M | 12.85M | 7.81M | 10.64M | 13.23M | 16.16M | 16.27M | 26.65M | 15.07M | 16.02M | 18.22M | 12.76M | 11.43M | 10.07M | n/a | n/a | n/a | n/a |
Pretax Income | 312.46M | 259.22M | 149.24M | 147.16M | 99.55M | 20.9M | -85.35M | -98.3M | -105.92M | -243.43M | -350.77M | 229.34M | -367.46M | -336.94M | -430.97M | -551.24M | -557.59M | -421.25M | -586.8M | -433.08M | -480.57M | 61.87M |
Net Income | 237.01M | 227.36M | 66.5M | 124.84M | 94.32M | 1.27M | -151.88M | -121.35M | -120.41M | -251.15M | -367.55M | 215.41M | -381.14M | -348.43M | -445.34M | -557.56M | -565.73M | -435.2M | -585.65M | -438.11M | -480.34M | 66.5M |
Selling & General & Admin | 593.21M | 555.1M | 555.29M | 529M | 537.91M | 459.29M | 504.68M | 455.22M | 443.73M | 427.43M | 416.55M | 365.71M | 395.03M | 328.5M | 328.98M | 322.89M | 331.4M | 294.57M | 306.5M | 269.23M | 232.29M | 182.11M |
Research & Development | 612.28M | 541.22M | 615.42M | 523.66M | 524.9M | 481.89M | 542.01M | 496.18M | 454.47M | 460.64M | 493.99M | 453.26M | 422.76M | 408.58M | 446.02M | 426.36M | 378.21M | 389.92M | 430.49M | 351.94M | 356.09M | 320.73M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.84M | n/a | 188K | 187K | 188K | 187K | 188K | 188K | 187K | 188K | 187K | 188K |
Operating Expenses | 1.21B | 1.1B | 1.17B | 1.05B | 1.06B | 941.18M | 1.05B | 951.4M | 898.2M | 888.07M | 912.37M | 818.97M | 817.99M | 737.27M | 775.2M | 749.44M | 709.8M | 684.68M | 737.17M | 621.35M | 588.57M | 503.02M |
Interest Expense | 39.74M | 32.89M | n/a | n/a | n/a | 7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.48M | 2.23M | 4.87M | 4.18M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.38B | 1.26B | 1.31B | 1.25B | 1.23B | 1.11B | 1.21B | 1.12B | 1.04B | 1.01B | 1.02B | 915.28M | 913.98M | 819.06M | 848.72M | 825.99M | 780.97M | 749.91M | 785.72M | 668.77M | 624.83M | 535.71M |
Income Tax Expense | 75.45M | 31.86M | 82.74M | 22.32M | 5.23M | 19.63M | 66.53M | 23.05M | 14.49M | 7.72M | 16.78M | 13.93M | 13.67M | 11.49M | 14.37M | 6.32M | 8.14M | 13.95M | -1.15M | 5.04M | -230K | -4.63M |
Shares Outstanding (Basic) | 111.58M | 110.96M | 109.06M | 110.22M | 108.57M | 106.93M | 106.26M | 104.7M | 104.7M | 104.27M | 104.08M | 104.67M | 104.63M | 104.17M | 103.76M | 103.48M | 102.8M | 102.46M | 95.03M | 92.77M | 91.85M | 91.46M |
Shares Outstanding (Diluted) | 115.8M | 115.77M | 113.45M | 114.52M | 112.85M | 111.17M | 106.26M | 104.7M | 104.7M | 104.27M | 104.08M | 106.95M | 104.63M | 104.17M | 103.76M | 103.48M | 102.8M | 102.46M | 95.03M | 92.77M | 91.85M | 96.73M |
EPS (Basic) | 27.04 | 26.65 | 7.67 | 14.69 | 0.87 | 0.01 | -1.43 | -1.16 | -1.15 | -2.47 | -25.48 | 2.08 | -3.64 | -3.38 | -30.55 | -5.33 | -5.59 | -4.29 | -6.11 | -4.42 | -5.20 | 0.78 |
EPS (Diluted) | 26.65 | 25.35 | 6.76 | 13.52 | 0.84 | 0.01 | -1.43 | -1.16 | -1.15 | -2.47 | -25.48 | 1.95 | -3.64 | -3.38 | -30.55 | -5.33 | -5.59 | -4.29 | -6.11 | -4.42 | -5.20 | 0.65 |
EBITDA | 392.71M | 333.25M | 248.97M | 184.45M | 135.16M | 60.71M | -35.11M | -27.01M | -81.81M | -218.13M | -326.95M | 250.85M | -345.13M | -316.93M | -412.95M | -535.04M | -542.12M | -404.65M | -569.2M | -418.67M | -464.18M | 79.8M |
EBIT | 352.2M | 292.1M | 212.99M | 147.16M | 99.55M | 27.9M | -85.35M | -98.3M | -105.92M | -243.43M | -350.77M | 229.34M | -367.46M | -336.94M | -430.97M | -551.24M | -557.59M | -421.25M | -582.32M | -430.85M | -475.71M | 70.17M |
Depreciation & Amortization | 40.52M | 41.14M | 35.98M | 37.28M | 35.61M | 32.8M | 50.25M | 71.29M | 24.11M | 25.29M | 23.82M | 21.51M | 22.34M | 20.01M | 18.02M | 16.2M | 15.46M | 16.6M | 13.12M | 12.18M | 11.53M | 9.63M |
Add to Watchlist
Select watchlists to add or remove ONC